This guide will build on what already works well in respiratory prescribing and encourage further quality improvement within NHS Scotland. It highlights key respiratory prescribing indicators, and it is hoped that clinicians will reflect on their current practice in prioritised areas. It should be read in conjunction with clinical guidance such as SIGN or NICE - it is not intended to replace them. The guidance has four main sections on Asthma, COPD, Bronchiectasis and Interstitial Lung Disease focusing on Idiopathic Pulmonary Fibrosis.
Environmental considerations for respiratory prescribing are introduced and explored. NHS Scotland has committed to be a ‘net-zero’ greenhouse gas emissions organisation by 20401 with more patients interested in their own carbon footprint.
We refer to ‘patients’ throughout, and recognise that different terminology is often used in official documentation. We recognise that patients are people who are managing different medical conditions, including respiratory disease.